Product image of Halciderm (Halcinonide) supplied by GNH India

Halciderm

Active Ingredient:
Halcinonide
Origin:
EU

Halciderm (Halcinonide)

Halciderm is a prescription topical medication that contains the corticosteroid halcinonide as its active ingredient. It is formulated for skin application and is marketed in the European Union. Halciderm belongs to the class of glucocorticoid receptor agonists and is used to reduce inflammation and immune responses in various dermatologic conditions. The product is supplied without a specified strength, and it is intended for short‑term use under medical supervision.

Manufacturer / TM Owner

Teofarma S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Halciderm is indicated for the topical treatment of several inflammatory skin disorders where reduction of redness, scaling, and itching is desired.

  • Psoriasis plaques, especially chronic plaque type
  • Atopic dermatitis (eczema) with moderate to severe inflammation
  • Contact dermatitis that is refractory to non‑steroidal measures
  • Seborrheic dermatitis involving scalp or facial areas
  • Lichen planus lesions that require anti‑inflammatory therapy

Side Effects

Side effects of Halciderm vary with duration of use, application area, and individual sensitivity.

Common

  • Burning or stinging at the site of application
  • Mild skin irritation or itching
  • Dryness or peeling of the treated area

Serious

  • Skin atrophy or thinning with prolonged use
  • Development of telangiectasia (visible small blood vessels)
  • Secondary infection of the skin (bacterial, fungal, or viral)

Precautions & Warnings

When using Halciderm, certain precautions help minimize risks and ensure safe treatment.

  • Avoid application on broken or infected skin unless directed by a clinician
  • Limit treatment duration to the shortest effective period to reduce risk of skin atrophy
  • Do not apply under occlusive dressings unless specifically prescribed
  • Use caution in patients with diabetes, hypertension, or glaucoma, as systemic absorption may exacerbate these conditions
  • Pregnant or breastfeeding women should consult a healthcare professional before use
  • Children under 12 years should be treated only under medical supervision

Avoid Interactions

Halciderm may interact with other medications or therapies applied to the skin.

Avoid

  • Concurrent use of other potent topical corticosteroids on the same area
  • Systemic glucocorticoids or immunosuppressants that may increase risk of systemic effects

Use with caution

  • Antifungal or antibacterial agents applied to the same site, as they may alter the skin barrier
  • Phototherapy (UVB) when combined with Halciderm, potentially increasing skin sensitivity
  • Herbal or over‑the‑counter skin products containing irritants or allergens

Frequently Asked Questions

Halciderm is prescribed for inflammatory skin disorders such as psoriasis, atopic dermatitis (eczema), contact dermatitis, seborrheic dermatitis, and lichen planus.

Apply a thin layer of the medication to clean, dry skin once or twice daily as directed by a healthcare professional, and gently rub it in until it disappears.

Treatment should be limited to the shortest period that provides clinical benefit, typically a few weeks, and should be re‑evaluated by a clinician before extending use.

Children under 12 years may use Halciderm only under medical supervision, with careful monitoring for local side effects and limited treatment areas.

The safety of Halciderm in pregnancy and lactation has not been established; women who are pregnant, planning pregnancy, or breastfeeding should discuss risks with their healthcare provider.

Common side effects include a burning or stinging sensation, mild irritation or itching, and dryness or peeling of the skin at the application site.

Stop using Halciderm and contact a healthcare professional if you notice severe skin thinning, persistent redness, new infections, or any signs of an allergic reaction such as swelling or rash.

Concurrent use with other potent topical corticosteroids should be avoided, and any additional skin products should be discussed with a clinician to prevent interactions.

Using systemic glucocorticoids or immunosuppressive drugs together with Halciderm may increase the risk of systemic corticosteroid effects and should be evaluated by a physician.

Halciderm contains halcinonide, a high‑potency corticosteroid, which provides strong anti‑inflammatory action; potency, formulation, and approved indications may differ from other corticosteroid products.

A mild burning sensation is a common initial reaction; if it persists, worsens, or is accompanied by severe irritation, discontinue use and consult a healthcare professional.

Store Halciderm at room temperature, away from excess heat and moisture, and keep the container tightly closed when not in use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Halcinonide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT